Clinical Trial Update: To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is underway to evaluate the safety of mitapivat and provide proof-of-concept of its efficacy in patients with RBC membranopathies, incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Dyserythropoietic Anemia Type Ii

Drugs mentioned

• Mitapivat (mitapivat)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Anemia | Phase 2 | Status: RECRUITING